Evidence map›Paper›PMID 32300433›Full record

ArticleJournal of hematology2018

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator.

Jose L Lepe-Zuniga, Francisco Javier Jeronimo-Lopez, Jorge Gregorio Hernandez-Orantes, Adriana Osiris Mendez-Cigarroa

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jose L Lepe-ZunigaHospital de Especialidades Pediatricas, Tuxtla Gutierrez, Chiapas, Mexico.
Francisco Javier Jeronimo-LopezHospital de Especialidades Pediatricas, Tuxtla Gutierrez, Chiapas, Mexico.
Jorge Gregorio Hernandez-OrantesHospital de Especialidades Pediatricas, Tuxtla Gutierrez, Chiapas, Mexico.
Adriana Osiris Mendez-CigarroaHospital de Especialidades Pediatricas, Tuxtla Gutierrez, Chiapas, Mexico.
Hospitales Regionales de Alta Especialidad · MXTuxtla Gutierrez Institute of Technology · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggressive natural killer (NK)-cell leukemia (ANKL) is a very rare oncohematological disease among youngsters in Latin America. Its clinical picture imitates a variety of syndromes and diseases due to its pathophysiology. Its diagnosis is relatively simple due to the prominence of NK malignant cells in peripheral blood and its clinical aggressiveness. In certain circumstances though, the presence of blast NK cells and the natural course of the disease can be so modified by the treatment of one of the imitated diseases, especially when using steroids, that it becomes very difficult to diagnose early in its course. We present a case of a 16-year-old Mexican male who initiated symptoms imitating dengue to severe dengue for which he received steroids, apparently inducing a partial remission; he was then diagnosed as having community acquired pneumonia, then sepsis, septic shock w/disseminated intravascular coagulation, primary hemophagocytic syndrome, severe hepatitis, lupus and finally hyper IgE. It was not until 1 day before dying of hemorrhagic shock, a month after initiating symptoms, when the (re)emergence of blast NK cells in peripheral blood allowed the correct diagnosis to be made. Knowledge of ANKL pathophysiology may raise awareness of this multifaceted malignancy and may open up possibilities for its therapy. Gained knowledge can also be used for guiding NK cell evident aggressiveness against other malignancies.

Indexed as

Acute leukemiaHemophagocytic syndromeLeukemiaNK cellNK-cell leukemia

Identifiers

PMID32300433
PMCPMC7155853
OpenAlexW2901886089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.